Congrats! YHLO Received CE mark on COVID-19 Ag Self-Test Kit
Recently, YHLO proudly announced that the COVID-19 self-test kit, GLINE-2019-nCoV Ag, has received the EC Certificate from the Polish Centre for Testing and Certification (POLSKIE CENTRUM BADAN I CERTYFIKACJI S.A.).
The EC Certificate is quality proof that YHLO’s COVID-19 self-test kit is well-qualified to be applied in the global market. Just as GLINE-2019-nCoV Ag can effectively detect the recently-emerged SARS-CoV-2 variant Omicron, as well as other Variants of Concern, YHLO’s self-test product is capable of facing upcoming challenges with deliberate product design and assured quality. YHLO always strives to provide accurate and efficient immunoassays to better help the world to fight against COVID-19.
Attachments:
MORE NEWS
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
2025-11-20
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
2025-11-18
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
